Page last updated: 2024-08-25

1,2,3,4-tetrahydroquinoline and Cancer of Prostate

1,2,3,4-tetrahydroquinoline has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Albadari, N; Gu, L; Li, W; Liu, T; Wang, R; Wu, Z; Xie, Y; Zhou, M1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Cancer of Prostate

ArticleYear
Synthesis and biological evaluation of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold.
    European journal of medicinal chemistry, 2023, Jul-05, Volume: 255

    Topics: Animals; Apoptosis; Cell Line, Tumor; Child; Humans; Leukemia, Myeloid, Acute; Male; Mice; Prostatic Neoplasms; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein

2023